Patents/Inventors

Matthew W. Martin

Arlington, MAUS5 patents

6 Patents

US124798072025
Methods Using HDAC11 Inhibitors
VALO HEALTH, Inc.
0 cites
US122641372025
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids as HDAC Inhibitors
VALO HEALTH, Inc.
0 cites
US120494662024
Fused Bicyclic Compounds Useful as Ubiquitin-specific Peptidase 30 Inhibitors
FORMA Therapeutics, Inc.
0 cites
US119198392024
Alpha-cinnamide Compounds and Compositions as HDAC8 Inhibitors
VALO HEALTH, Inc.
0 cites
US118913652024
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids as HDAC Inhibitors
VALO HEALTH, Inc.
0 cites
US118143862023
Fused Pyrrolines Which Act as Ubiquitin-specific Protease 30 (USP30) Inhibitors
FORMA Therapeutics, Inc.
0 cites